glp-1 clinical trials sign up Boston biotech secures Series A funding to move its once-weekly obesity patch into first-in-human trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech GLP-1 Receptor Agonist Market to

Employers are not asking for anything radical

Piriton (chlorphenamine) can be used with escitalopram but should be approached with caution, as the combination may cause additive sedation and increased anticholinergic effects such as dry mouth, blurred vision, and urinary retention

GLP1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists

However, limit use to 2-3 days per week to prevent medication-overuse headaches, and consult your healthcare provider if you have kidney disease, cardiovascular conditions, or take anticoagulants

The connection between stress and GLP-1 function runs deeper than most people realize

As of mid-2026, neither cagrilintide nor retatrutide is approved by the FDA or EMA for any indication